Table 2 Description of cases of culture proven Candida sepsis before the prophylaxis era, including species, source and outcome.
Case | Birth weight (g) | Gestational age (weeks) | Age at Candida sepsis (days) | Species | Source | Risk factors | Outcome |
---|---|---|---|---|---|---|---|
1 | 900 | 25 | 10 | C albicans | Blood and CSU | Cephalosporin, >10/7 AB*, FC and CVC | Died, day 83 |
2 | 615 | 23 | 15 | C parapsilosis | Blood | Cephalosporin | Died, day 28 |
3 | 752 | 25 | 28 | C parapsilosis and C albicans | Blood and urine | Cephalosporin, >10/7 AB | Died, day 42 |
4 | 923 | 30 | 23 | C albicans | Blood and urine | >10/7 AB | Alive, home day 57 |
5 | 630 | 24 | 20 | C parapsilosis | Ascites | Cephalosporin | Alive, home day 170 |
6 | 660 | 24 | 19 | C albicans | Urine | FC and CVC, >10/7 AB | Died, day 39 |
CSU, catheter specimen urine; CVC, central venous catheter; FC, fungal colonisation.
*10/7 AB, more than 10 days consecutive systemic antibiotics.